mucos
resist
infect
lactat
dehydrogenaseelev
viru
ldv
previous
demonstr
ldv
system
present
import
murin
model
studi
mucos
barrier
viral
infect
present
studi
duoden
molecul
isol
normal
mice
potent
virucid
activ
test
ldv
well
canin
herp
canin
hepat
semliki
forest
visna
virus
virucid
activ
demonstr
nonimmun
natur
present
appar
nonenzymat
protein
molecul
molecular
mass
kda
membran
filtrat
kda
gel
filtrat
antildv
activ
molecul
suppress
antiduodenum
antibodi
vitro
vivo
studi
suggest
possibl
protect
role
antivir
molecul
conclud
normal
mous
duodenum
contain
potent
virucid
molecul
interest
studi
biolog
molecular
mechan
viral
resist
correspond
wa
cafruni
mucos
surfac
play
import
role
protect
potenti
host
viral
infect
thu
signific
pathogenesi
varieti
human
anim
virus
protect
mucos
site
may
mediat
physic
chemic
mechan
restrict
attach
virus
host
target
cell
braud
viral
infect
intact
mucos
site
may
requir
larg
number
virion
ie
minimum
infecti
dose
mid
suffici
overwhelm
mucos
defens
mechan
ward
akin
although
defens
mechan
incomplet
understood
may
includ
antibodi
specif
well
nonspecif
molecul
disabl
virus
ward
akin
presenc
nonspecif
antivir
molecul
describ
human
saliva
fultz
archibald
cole
bovin
milk
panon
et
al
molecul
may
repres
protect
barrier
viru
infect
lactat
dehydrogenaseelev
viru
ldv
murin
togaviru
caus
persist
infect
rowson
mahi
cafruni
mechan
persist
relat
infect
permiss
subpopul
macrophag
continu
evolv
vivo
well
inabl
immun
respons
clear
viru
rowson
mahi
cafruni
bradley
et
al
power
rel
mucos
barrier
ldv
infect
demonstr
mid
virion
oral
administ
ldvi
contrast
mid
one
virion
parenter
exposur
cafruni
hovinen
natur
mucos
barrier
ldv
infect
clear
consist
part
nonspecif
biochem
factor
appear
prostaglandinsensit
present
studi
ldvinhibitori
molecul
investig
nonimmun
mous
gastrointestin
tract
extract
mous
small
intestin
character
antildv
activ
studi
antivir
spectrum
chemic
natur
extract
also
carri
data
show
mous
duodenum
contain
potent
antivir
molecul
virucid
varieti
unrel
virus
femal
outbr
mice
strain
obtain
week
age
sasco
inc
omaha
amitech
omaha
mice
maintain
standard
lab
chow
tap
water
ad
libitum
mice
sacrif
cervic
disloc
stomach
intestin
remov
place
cold
phosphatebuff
salin
pb
ph
intact
gut
rins
well
cold
pb
variou
segment
describ
place
glass
tissu
grinder
complet
grind
tissu
tissu
remnant
allow
settl
sever
minut
supernat
clarifi
centrifug
g
min
follow
steril
filtrat
filter
protein
determin
carri
measur
optic
densiti
nm
dyebind
assay
biorad
total
protein
standard
mgml
extract
extract
store
experi
extract
organ
made
ident
procedur
prepar
mucos
extract
duoden
mucosa
scrape
free
intestin
wall
suspend
pb
brush
border
membran
prepar
describ
kessler
et
al
small
intestin
tcell
obtain
noncontinu
gradient
floatat
describ
previous
dillon
macdonald
enzym
inhibit
carri
describ
previous
gaspari
et
al
briefli
tissu
extract
incub
soybean
trypsin
inhibitor
mgml
edta
phenylmethylsulfonylfluorid
ram
sodium
azid
mgml
min
end
incub
period
treat
extract
compar
control
untreat
extract
antildv
activ
igg
iga
absorb
tissu
extract
appropri
affin
column
protein
asepharos
igg
antimous
iga
column
prepar
affinityadsorb
antimous
iga
southern
biotechnolog
conjug
cyanogen
bromideactiv
sepharos
iga
specif
adsorpt
demonstr
western
blot
analys
also
show
detect
igg
iga
remov
crude
extract
affin
column
heat
treatment
carri
heat
aliquot
block
heater
min
experi
tissu
extract
precipit
ammonium
sulfat
min
follow
centrifug
x
g
min
supernat
collect
ultracentrifug
filtrat
tissu
extract
carri
describ
text
ldv
stock
plagemann
strain
ldvp
cafruni
plagemann
prepar
plasma
mice
h
postinfect
pi
titrat
describ
plagemann
et
al
briefli
serial
dilut
viru
stock
prepar
cold
pb
ml
dilut
inject
intraperiton
indic
mice
four
day
follow
inject
indic
mice
bled
plasma
ldh
level
determin
titrat
endpoint
calcul
highest
dilut
yield
rise
plasma
ldh
characterist
ldv
infect
stock
viru
frozen
aliquot
contain
inactiv
ldv
assess
vitro
compar
concentr
infecti
ldv
experiment
tube
contain
variou
test
extract
concentr
ldv
control
tube
experi
tissu
extract
contain
total
protein
concentr
approxim
mgml
incub
final
volum
ml
ldv
virus
describ
text
ldvrna
label
uridin
analyz
sucros
densiti
ultracentrifug
describ
previous
brintondarnel
plagemann
canin
kidney
mdckusd
cell
gaush
smith
cultur
eagl
mem
supplement
fetal
bovin
serum
use
growth
canin
herp
viru
atcc
rr
strain
infecti
canin
hepat
viru
lederl
research
refer
reagent
vaccinia
viru
obtain
dr
c
gaush
american
red
cross
laboratori
bethesda
md
virus
titrat
plaqu
assay
essenti
describ
previous
use
cultur
plate
per
dilut
gaush
smith
semliki
forest
viru
atcc
lth
passag
mous
brain
grown
establish
deer
kidney
cell
line
cultur
dmem
supplement
fc
visna
viru
atcc
grown
sheep
choroid
plexu
cell
cultur
medium
supplement
lamb
serum
confluent
cell
inocul
plate
ml
viru
incub
day
cell
fix
buffer
formalin
stain
crystal
violet
plaqu
count
triplic
cultur
small
intestin
extract
clarifi
x
g
min
filter
filter
separ
sephadex
column
column
x
cm
contain
total
void
volum
ml
determin
dextran
blue
total
bed
volum
ml
small
intestin
extract
mg
total
protein
molecular
weight
marker
run
column
buffer
contain
mm
mm
mm
mm
mm
fraction
ml
collect
absorb
nm
determin
fraction
consecut
fraction
serial
pool
dialyz
h
distil
frozen
lyophil
analysi
antivir
activ
lyophil
column
fraction
reconstitut
ml
pb
incub
viru
stock
min
young
adult
new
zealand
white
rabbit
immun
extract
prepar
mous
small
intestin
first
inject
mg
mous
duodenum
given
freund
adjuv
administ
subcutan
follow
weekli
inject
mg
duodenum
extract
given
iv
week
rabbit
immun
mg
duodenum
iv
monitor
antiduodenum
titer
elisa
indic
increas
level
antiduodenum
igg
week
rabbit
sacrif
serum
collect
antiduodenum
igg
titer
elisa
antiserum
also
display
broad
reactiv
mous
duodenum
western
immunoblot
data
shown
serum
use
oral
administr
pipet
normal
mice
prior
exposur
limit
dose
ldv
oral
rout
cafruni
hovinen
mice
evalu
day
later
ldv
infect
rabbit
serum
also
test
antildv
inhibitor
activ
direct
vitro
mix
ldv
inhibitor
control
rabbit
serum
unimmun
rabbit
use
experi
control
antibodi
rabbit
immun
irrelev
antigen
mycoplasma
fraction
freund
adjuv
also
use
demonstr
specif
cultur
mous
macrophag
infect
ldv
multipl
describ
previous
stueckemann
et
al
detect
infect
fluoresc
antibodi
analysi
infect
cell
fix
aceton
h
pi
cafruni
et
al
initi
experi
small
intestin
excis
normal
mice
wash
ph
pb
ground
glass
tissu
grinder
ml
pb
intestin
extract
clarifi
centrifug
g
min
filter
filter
store
total
protein
content
standard
approxim
mgml
reaction
tube
set
contain
tissu
extract
ldv
final
viru
concentr
shown
fig
extract
mous
small
intestin
found
inactiv
ldv
vitro
prior
inject
indic
mice
fig
absenc
lag
phase
kinet
inactiv
indic
atissu
extract
prepar
normal
mice
describ
materi
method
total
protein
concentr
equal
mgml
bmean
inhibit
start
viru
concentr
shown
ldv
titer
determin
use
dilut
reaction
tube
sampl
titrat
immedi
min
incub
addit
tissu
extract
clnhibitori
activ
seen
one
experi
incub
extend
min
singlehit
mechan
viral
inactiv
mandel
incub
viru
control
tube
contain
pb
normal
mous
plasma
fail
result
viru
inactiv
time
period
studi
experi
also
perform
ldv
incub
extract
normal
mous
duodenum
ileum
jejunum
stomach
liver
spleen
heart
lung
kidney
shown
tabl
virucid
activ
concentr
duodenum
lower
concentr
observ
ileum
jejunum
lung
thu
viral
inhibitori
molecul
anatom
restrict
ldv
inactiv
simpli
due
presenc
compar
concentr
mous
protein
biomolecul
enzym
present
tissu
duodenum
ldv
inhibitor
observ
brush
boarder
membran
tcellenrich
fraction
duodenum
purifi
fraction
test
protein
concentr
mg
ml
data
shown
demonstr
restrict
local
inhibitor
within
cell
duodenum
ldv
inactiv
duoden
extract
temperaturedepend
sinc
rate
viral
inactiv
greater
data
shown
addit
antildv
effect
depend
linear
fashion
concentr
extract
use
reaction
tube
small
intestin
extract
less
mgml
dyebind
protein
assay
rare
activ
high
titer
viru
data
shown
hypothesi
ldv
inactiv
mous
duodenum
extract
due
enzym
test
preincub
duodenum
extract
sever
compound
known
inactiv
rang
proteas
normal
present
aldv
concentr
incub
duoden
extract
pretreat
indic
tabl
describ
text
ldv
titer
determin
pre
post
incub
min
untreat
treat
extract
extract
mous
food
see
text
method
bldv
titer
shown
unit
mammalian
gut
gaspari
et
al
pretreat
phenylmethylsulfonyl
fluorid
pmsf
sodium
azid
edta
soybean
trypsin
inhibitor
effect
abil
mous
duoden
extract
inactiv
ldv
shown
tabl
tabl
also
show
result
experi
duoden
ldv
inhibitor
precipit
ammonium
sulfat
pellet
centrifug
g
rain
inhibitor
recov
resuspens
pb
ammonium
sulfat
well
ultracentrifug
pellet
inhibitor
also
pass
filter
mw
cutoff
dalton
retain
filter
cutoff
dalton
tabl
determin
inhibitor
exogen
food
product
solubil
mous
food
shown
antildv
effect
tabl
taken
togeth
data
show
ldv
inhibitor
mous
duodenum
proteinlik
kda
macromolecul
suggest
possibl
nonenzymat
mechan
action
duoden
extract
subject
heat
test
antildv
activ
treatment
rain
enhanc
antildv
activ
sinc
viru
reduc
untreat
duoden
extract
heat
extract
data
shown
effect
routin
observ
number
experi
antildv
activ
retain
extent
unheat
prepar
antildv
activ
destroy
data
shown
result
show
duoden
antildv
activ
due
complementmedi
reaction
support
nonenzymat
natur
antildv
activ
mous
duoden
extract
absorb
either
protein
asepharos
immunoadsorb
prepar
activ
sepharos
affinitypurifi
goat
antimous
iga
treatment
remov
detect
igg
iga
respect
mous
extract
determin
western
analys
data
shown
experi
absorb
extract
retain
full
antildv
activ
inactiv
data
shown
show
activ
due
presenc
igg
iga
antibodi
small
intestin
extract
fraction
sephadex
fraction
correspond
molecular
mass
kda
contain
total
protein
elut
smaller
amount
protein
distribut
throughout
remaind
column
fraction
data
shown
tabl
show
result
independ
experi
differ
small
intestin
extract
fraction
sephadex
test
antildv
activ
inhibit
viral
infect
seen
fraction
correspond
molecular
weight
kda
estim
standard
curv
prepar
carbon
anhydras
kda
alcohol
dehydrogenas
kda
fraction
contain
total
protein
well
shamprepar
fraction
consist
elut
pb
display
antildv
activ
result
show
signific
purif
small
intestin
viral
inhibitor
possibl
sinc
sephadex
fraction
contain
antivir
activ
total
protein
concentr
rang
mg
ml
fraction
small
intestin
extract
sephadex
result
essenti
ident
data
obtain
fraction
shown
tabl
antildv
activ
contain
column
fraction
correspond
molecular
weight
approxim
kda
ldvinhibitori
column
fraction
test
semliki
forest
viru
pretreat
x
pfuml
approxim
inactiv
posttreat
titer
pfuml
aldv
incub
kda
fraction
small
intestin
extract
min
preand
postincub
titer
determin
column
fraction
similarli
assay
detect
antildv
activ
data
shown
ldv
titer
shown
unit
brintondarnel
plagemann
fig
show
sucros
densiti
gradient
profil
label
intact
virion
also
result
analys
label
virion
treat
duoden
extract
prior
centrifug
sucros
densiti
gradient
untreat
intact
virion
migrat
within
sucros
gradient
singl
major
peak
repres
densiti
gcc
brintondarnel
plagemann
pretreat
label
intact
virion
mgml
heat
min
mous
duoden
extract
rain
littl
effect
sucros
densiti
gradient
profil
peak
within
ml
repres
experi
shown
fig
suggest
ldv
inactiv
mous
duoden
inhibitor
due
gross
disrupt
virion
contrast
incub
intact
label
virion
nonheat
duoden
extract
extens
disrupt
virion
shown
loss
uridinelabel
peak
result
explain
sensit
tissueculturederiv
ldv
enzym
trypsin
kowalchyk
plagemann
broen
cafruni
unpublish
data
contrast
blood
plasmaderiv
viru
protect
action
trypsin
probabl
factor
crispen
broen
cafruni
unpublish
data
thu
heat
duoden
extract
elimin
extran
factor
disrupt
tissueculturederiv
viru
preserv
antildv
activ
allow
analysi
absenc
factor
may
disrupt
virion
brintondarnel
plagernann
standard
label
viru
display
peak
gcc
brintondarnel
plagemann
viru
also
analyz
min
incub
duoden
extract
duoden
extract
heat
min
vivo
experi
mice
dose
time
rain
preldvexposur
rabbit
antimous
duodenum
normal
rabbit
serum
posit
expt
refer
mice
becom
ldv
infect
oral
ldv
challeng
n
number
mice
cumul
consecut
experi
expt
b
ldv
inhibitor
incub
rabbit
antimous
duodenum
min
prior
min
incub
ldv
inocul
mous
macrophag
cultur
gaspari
et
al
cafruni
plagemann
antiduodenum
antibodi
alon
effect
replic
ldv
mous
macrophag
cultur
separ
control
experi
shown
control
ab
rabbit
immun
irrelev
ag
mycoplasma
fraction
freund
adjuv
fail
inactiv
duoden
inhibitor
repres
data
shown
two
independ
experi
expt
b
indic
cultur
macrophag
becom
ldv
infect
vitro
infect
rabbit
antiduodenum
antibodi
prepar
studi
activ
ldv
inhibitor
mice
given
two
oral
dose
rabbit
antiduodenum
antiserum
prior
oral
challeng
limit
dose
ldv
signific
increas
rate
ldv
infect
rel
mice
given
control
normal
rabbit
serum
tabl
antiinhibitor
activ
rabbit
antiserum
also
demonstr
vitro
sinc
incub
ldv
inhibitor
min
prior
infect
cultur
mous
macrophag
result
abrog
viru
infect
repres
experi
show
tabl
effect
revers
presenc
antiduodenum
antibodi
control
experi
employ
normal
rabbit
serum
rabbit
antibodi
irrelev
antigen
tabl
demonstr
immun
specif
antiduodenum
antibodi
infecti
canin
hepat
viru
canin
herp
viru
vaccinia
viru
semliki
forest
viru
visna
viru
incub
normal
mous
duoden
extract
min
appropri
control
prepar
infect
indic
cell
determin
viru
titer
plaqu
assay
shown
tabl
hepat
herp
semliki
forest
visna
virus
suscept
virucid
effect
mous
duoden
extract
vaccinia
viru
resist
contrast
case
ldv
extract
mous
tissu
show
vari
degre
viral
inhibit
virus
data
shown
exampl
stomach
extract
found
inhibit
canin
herp
hepat
vaccinia
virus
case
stomach
heat
rain
abrog
inhibitori
activ
canin
hepat
viru
visna
viru
inhibit
mous
stomach
extract
extent
duodenum
extract
assess
effect
heat
stomach
extract
visna
system
pretreat
tissu
cultur
cell
duodenum
small
intestin
extract
effect
viru
replic
show
antivir
effect
due
inhibit
cellular
metabol
cytotox
activ
result
signific
describ
appar
novel
antivir
molecul
whose
action
virucid
limit
particular
viru
class
virus
proteinlik
molecul
nonimmun
natur
sinc
stabil
elimin
possibl
known
complementmedi
pathway
sinc
absorpt
essenti
igg
iga
activ
crude
extract
fail
diminish
activ
thu
naturallyoccur
antibodi
immun
factor
play
role
duoden
antildv
activ
also
first
report
nonantibodi
physiolog
inhibitor
ldv
normal
resist
inactiv
whole
mous
plasma
well
serum
speci
insensit
ldv
inhibitor
enzymedeactiv
agent
along
stabil
support
enzymemedi
mechan
ldv
present
plasma
acutelyinfect
mice
stock
ldv
previous
shown
proteaseinsensit
crispen
although
gradientpurifi
ldv
may
inactiv
high
concentr
trypsin
kowalchyk
plagemann
broen
cafruni
unpublish
data
plasma
appar
protect
ldv
trypsin
possibl
enzym
effect
observ
appear
due
enzymat
degrad
viru
gel
filtrat
experi
suggest
antildv
activ
mous
small
intestin
extract
restrict
molecul
molecular
mass
approxim
kda
use
estim
molar
coeffici
antildv
activ
may
calcul
figur
must
view
estim
sinc
molecul
respons
viru
inactiv
yet
clearli
identifi
may
potenti
undergo
degre
dissoci
alter
gel
filtrat
gel
filtrat
result
purif
antildv
activ
signific
attempt
character
antivir
activ
inhibit
semliki
forest
viru
occur
purifi
molecul
activ
ldv
suggest
possibl
dual
effect
purifi
molecul
howev
appear
like
factor
present
intestin
stomach
extract
may
respons
inactiv
canin
herp
vaccinia
virus
sinc
heat
stomach
extract
also
inactiv
virus
consist
presenc
divers
rang
potenti
antivir
molecul
site
import
note
extract
varieti
mous
tissu
well
normal
mous
plasma
nonvirucid
ldv
thu
duoden
antildv
activ
artifact
widelydistribut
tissu
enzym
bind
protein
compon
viral
inactiv
duodenum
extract
molecul
clearli
due
direct
effect
suscept
virus
sinc
viral
inactiv
occur
rapidli
vitro
furthermor
pretreat
cell
use
viru
plaqu
assay
fail
inhibit
viral
replic
exposur
normal
inoculum
might
expect
interferonlik
mechan
ldv
inactiv
kinet
fig
indic
singlehit
mechan
viral
inactiv
wherebi
singl
molecul
inhibitor
bind
viru
suffici
disabl
mandel
interest
sinc
mous
antibodi
produc
ldv
infect
neutral
viru
multihit
kinet
cafruni
et
al
howev
rabbit
igg
produc
ldv
neutral
viru
singlehit
kinet
suggest
interact
duoden
inhibitor
ldv
could
via
molecular
mechan
neutral
rabbit
antibodi
ldv
envelop
rna
viru
three
known
structur
protein
brintondarnel
plagemann
membraneassoci
glycoprotein
target
rabbit
neutral
antibodi
cafruni
et
al
well
recent
describ
neutral
mous
monoclon
antibodi
harti
plagemann
provid
like
receptorbind
molecul
necessari
interact
suscept
macrophag
cafruni
kowalchyk
plagemann
ldv
inactiv
duoden
molecul
could
due
analog
bind
disrupt
viru
structur
altern
could
result
membran
alter
independ
bind
sinc
heattreat
duodenum
extract
fail
markedli
alter
virion
densiti
appar
duoden
inhibitor
act
without
disrupt
entir
virion
like
disrupt
virion
observ
nonheattr
duodenum
extract
due
contribut
addit
heatsensit
factor
includ
enzym
common
inhibitor
pathway
deduc
data
sinc
virus
inhibit
duoden
molecul
repres
divers
viral
structur
genom
result
immun
studi
suggest
duoden
ldv
inhibitor
may
play
role
physiolog
defens
ldv
infect
sinc
mice
fed
antibodi
inhibitor
significantli
increas
rate
ldv
infect
subsequ
oral
exposur
ldv
ldv
infect
vitro
also
suscept
duoden
inhibitor
effect
destroy
incub
antiduodenum
antibodi
provid
confirm
immun
destruct
inhibitor
molecul
presenc
natur
viral
inhibitor
duodenum
mucos
site
would
adapt
advantag
mean
inhibit
virus
expos
site
might
signific
studi
antivir
mechan
studi
progress
character
viral
inhibit
natur
duoden
molecul
